Skip to main content
Equibles

Allianz Asset Management GmbH

Position in DHR — Danaher Corp /De/

CIK 1535323 MUNICH, 2M
Back to DHR Full portfolio

Position in DHR

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$18,868,043
-$3,983,209 QoQ
Shares Held
99,515
-0.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 72.42727227051198.ToString("F0")% Shared 0.ToString("F0")% None 27.572727729488015.ToString("F0")%

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Mar 31, 2026
CallValue
$6,503,280
CallShares
34,300
PutValue
$9,859,200
PutShares
52,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Allianz Asset Management GmbH holds $605,799,032 across 20 Diagnostics & Research names. DHR ranks #7 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 418,106 $205,511,640
2 IDXX
Idexx Laboratories Inc /De
 207,403 $116,537,670
3 LH
Labcorp Holdings Inc.
 214,847 $57,323,327
4 IQV
Iqvia Holdings Inc.
 293,532 $50,058,945
5 A
Agilent Technologies, Inc.
 358,177 $40,825,013
6 CSTL
Castle Biosciences Inc
 811,324 $19,918,003
7 DHR
Danaher Corp /De/
This page 		99,515 $18,868,043
8 QGEN
Qiagen N.V.
 427,030 $17,098,280

All Filings in DHR

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,859,200 52,000
2026-03-31 $6,503,280 34,300
2026-03-31 $18,868,043 99,515
2025-12-31 $22,851,252 99,822
2025-12-31 $6,661,572 29,100
2025-12-31 $8,264,012 36,100
2025-09-30 $7,831,270 39,500
2025-09-30 $5,055,630 25,500
2025-09-30 $34,410,996 173,565
2025-06-30 $10,153,556 51,400
2025-06-30 $5,669,398 28,700
2025-06-30 $57,600,687 291,590
2025-03-31 $61,160,315 298,343
2025-03-31 $9,368,500 45,700
2025-03-31 $7,605,500 37,100
2024-12-31 $109,788,711 478,278
2024-12-31 $3,626,890 15,800
2024-12-31 $8,103,115 35,300
2024-09-30 $2,724,596 9,800
2024-09-30 $139,084,228 500,267
2024-09-30 $4,809,746 17,300
2024-06-30 $4,247,450 17,000
2024-06-30 $157,210,115 629,218
2024-06-30 $3,522,885 14,100
2024-03-31 $159,909,948 640,357
2024-03-31 $174,804 700
2024-03-31 $299,664 1,200
2023-12-31 $141,804,708 612,971
2023-09-30 $156,009,583 709,306
2023-06-30 $152,590,878 717,177
2023-03-31 $154,053,180 689,462
2022-12-31 $162,120,310 688,990
2022-09-30 $157,615,060 688,334
2022-06-30 $202,866,815 902,626
2022-03-31 $249,410,046 959,106
2021-09-30 $220,435,596 816,750
2021-06-30 $186,224,945 782,761
2021-03-31 $123,115,761 617,001
2020-12-31 $116,898,007 593,594
2020-09-30 $107,046,502 560,760
2020-06-30 $105,993,917 676,136
2020-03-31 $96,356,793 785,279

Report a Problem

Category
Description
Email (optional, for follow-up)